Mepolizumab Reduces Exacerbations in Patients With Severe Eosinophilic Asthma, Irrespective of Body Weight/Body Mass Index: Meta-Analysis of MENSA and MUSCA
Respiratory Research - United Kingdom
doi 10.1186/s12931-019-1134-7
Full Text
Open PDFAbstract
Available in full text
Date
July 30, 2019
Authors
Publisher
Springer Science and Business Media LLC